ZYNLONTA
NDC 79952-110, loncastuximab tesirine, injection, powder, lyophilized, for solution, from ADC Therapeutics America, Inc..
- Product NDC
- 79952-110
- Status
- Listed
- Labeler
- ADC Therapeutics America, Inc.
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761196
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/79952-110 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LONCASTUXIMAB TESIRINE10 mg/2mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 79952-110-01 | 79952011001 | 1 VIAL, SINGLE-DOSE in 1 CARTON (79952-110-01) / 2 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/af54af12-3edf-4301-8bc5-0446bc813c1dMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=79952-110
Use it
Look up 79952-110 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/79952-110 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 79952-110. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.